Volume 5, number 2
 PDF Downloads: 939

Chlorcyclizine, an antihistamine, exhibiting antimetabolic activity and nonmutagenic behavior

Musfiqua  Mookerjee

NSHM College of Pharmaceutical Technology, NSHM Knowledge Campus, 124, B.L. Saha Road, Kolkata - 700 053 India.   Corresponding Author E-mail: musfiqua.mookerjee@nshm.com

ABSTRACT: Direct evaluation of the carcinogenicity of compounds, employing animal and tissue culture models are often dilatory, costly and less predictable. Opportunities for application of bacterial prescreens for their detection are being successfully explored because of the basic similarities of many of biochemical processes between the microbial and malignant mammalian cells. Several chemotherapeutic agents were screened employing two such bacterial prescreens for detecting their antimetabolic activity and subsequently determining mutagenicity, following Ame’s Test. From this study, Chlorcyclizine an antihistamine, structurally related to the phenothiazines emerged as a potential antimetabolite with nonmutagenic activity. Further invivo studies on malignant cell lines is suggested, with this promising drug chlorcyclizine to finally detect if it is endowed with anticarcinogenic property as well.

KEYWORDS:

prescreens; antimetabolic activity; anticarcinogenecity; chlorcyclizine

Download this article as: 
Copy the following to cite this article:

Mookerjee M. Chlorcyclizine, an antihistamine, exhibiting antimetabolic activity and nonmutagenic behavior. Biosci Biotechnol Res Asia 2008;5(2).
Copy the following to cite this URL:

Mookerjee M. Chlorcyclizine, an antihistamine, exhibiting antimetabolic activity and nonmutagenic behavior. Biosci Biotechnol Res Asia 2008;5(2).Available from:

[ HTML Full Text]

Back to TOC